Metabolic effects of some tumor-inhibitory pyridine carboxaldehyde thiosemicarbazones.
D000225:Adenine / Q000378:metabolism; D000447:Aldehydes / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000633:toxicity; D001202:Ascitic Fluid; D002247:Carbon Isotopes; D002452:Cell Count; D004273:DNA, Neoplasm / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D005260:Female; D005561:Formates / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D051379:Mice; D009368:Neoplasm Transplantation; D012334:RNA, Neoplasm / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D012510:Sarcoma 180 / Q000188:drug therapy / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism; D013882:Thiosemicarbazones / Q000494:pharmacology* / Q000633:toxicity; D013936:Thymidine / Q000378:metabolism; D014184:Transplantation, Homologous; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000447:Aldehydes; D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D005561:Formates; D012334:RNA, Neoplasm; D013882:Thiosemicarbazones; D014316:Tritium; D012964:Sodium; D007930:Leucine; D000225:Adenine; D013936:Thymidine; D014529:Uridine